Drug intelligence / Profile preview

Hyponidd

Development stage
Unknown
Lead developer
Charak
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hyponidd is a proprietary Ayurvedic herbal formulation developed and manufactured by Charak Pharma. It is designed to support metabolic wellness and reproductive health, primarily serving as an herbal insulin sensitizer. Hyponidd is commonly used in the management of type 2 diabetes mellitus and polycystic ovary syndrome (PCOS). The formulation contains a synergistic blend of traditional Ayurvedic herbs and minerals, including Vijaysaar (*Pterocarpus marsupium*), Haridra (*Curcuma longa*), Karela (*Momordica charantia*), Gudmar (*Gymnema sylvestre*), Amalaki (*Emblica officinalis*), and Guduchi (*Tinospora cordifolia*). These ingredients work together to improve insulin sensitivity, regulate glucose metabolism, reduce oxidative stress, and support hormonal balance and ovulation in women with PCOS.

Brand names
Hyponidd
Other names
Hyponidd TabletHyponidd Tablets

Beyond the preview

Go deeper on Hyponidd.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyponidd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call